mucosal melanoma
Showing 1 - 25 of 28
Anal Melanoma, Bladder Melanoma, Cervical Melanoma Trial in United States (Cabozantinib S-malate, Nivolumab, Placebo
Recruiting
- Anal Melanoma
- +18 more
- Cabozantinib S-malate
- +5 more
-
Los Angeles, California
- +53 more
Jan 31, 2023
Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma, Lentigo Maligna Melanoma Trial in United States (Dinaciclib)
Active, not recruiting
- Acral Lentiginous Melanoma
- +6 more
-
Mobile, Alabama
- +190 more
Jan 28, 2023
Acral Lentiginous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in
Active, not recruiting
- Acral Lentiginous Melanoma
- +3 more
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +822 more
Jan 28, 2023
Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)
Recruiting
- Metastatic Melanoma
- +9 more
- TBio-4101
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Mucosal Melanoma Trial in Wollstonecraft (Pembrolizumab, Lenvatinib)
Not yet recruiting
- Mucosal Melanoma
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Sep 15, 2022
Advanced Melanoma, Melanoma of Unknown Primary, Mucosal Melanoma Trial in United States (Ipilimumab, Nivolumab)
Active, not recruiting
- Advanced Melanoma
- +10 more
- Ipilimumab
- Nivolumab
-
Anchorage, Alaska
- +638 more
Aug 30, 2022
Cutaneous Melanoma, Mucosal Melanoma Trial in Worldwide (Nemvaleukin Alfa Subcutaneous, Nemvaleukin Alfa Intravenous)
Recruiting
- Cutaneous Melanoma
- Mucosal Melanoma
- Nemvaleukin Alfa Subcutaneous
- Nemvaleukin Alfa Intravenous
-
La Jolla, California
- +26 more
Aug 1, 2022
Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)
Not yet recruiting
- Recurrent Metastatic Melanoma
- +3 more
-
Boston, Massachusetts
- +1 more
Jul 29, 2022
Mucosal Melanoma Trial in New York (Nivolumab and/or Ipilimumab, Stereotactic Body Radiation Therapy (SBRT), axitinib)
Recruiting
- Mucosal Melanoma
- Nivolumab and/or Ipilimumab
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 14, 2022
Acral Melanoma, Mucosal Melanoma Trial in Seoul (Pembrolizumab, Vactosertib)
Not yet recruiting
- Acral Melanoma
- Mucosal Melanoma
- Pembrolizumab, Vactosertib
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jun 23, 2022
Melanoma, Melanoma (Skin), Moles Trial in Nizhny Novgorod, Moscow (Non-invasive adhesive system (patch))
Recruiting
- Melanoma
- +11 more
- Non-invasive adhesive system (patch)
-
Nizhny Novgorod, Russian Federation
- +1 more
Jun 12, 2022
Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly
Completed
- Cutaneous Melanoma
- +11 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +2 more
-
Chicago, Illinois
- +6 more
Nov 10, 2021
Cutaneous Melanoma, Mucosal Melanoma, Ocular Melanoma Trial in New York, Houston (biological, other, procedure)
Active, not recruiting
- Cutaneous Melanoma
- +10 more
- Ipilimumab
- +4 more
-
New York, New York
- +1 more
Aug 25, 2021
Mucosal Melanoma, Sinonasal Melanoma Trial in Shanghai (procedure, radiation, drug)
Recruiting
- Mucosal Melanoma
- Sinonasal Melanoma
- endoscopic surgery
- +2 more
-
Shanghai, Shanghai, ChinaEye& ENT Hospital, Fudan University
Aug 16, 2021
Melanoma, Metastatic Melanoma, Mucosal Melanoma Trial in Houston, Charlottesville (Peptide Vaccine (LPV7) + Tetanus peptide,
Unknown status
- Melanoma
- +2 more
- Peptide Vaccine (LPV7) + Tetanus peptide
- +3 more
-
Houston, Texas
- +1 more
Nov 15, 2020
Mucosal Melanoma, Neoadjuvant Treatment Trial in Beijing (Lenvatinib, Pembrolizumab)
Not yet recruiting
- Mucosal Melanoma
- Neoadjuvant Treatment
- Lenvatinib, Pembrolizumab
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Nov 10, 2020
Mucosal Melanoma Trial in Shanghai (Toripalimab, chemo in combination with Endostar)
Recruiting
- Mucosal Melanoma
- Toripalimab
- chemotherapy in combination with Endostar
-
Shanghai, Shanghai, ChinaZhiguo Luo
Jul 12, 2020
Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Mucosal Melanoma Trial in United States (Laboratory Biomarker
Completed
- Iris Melanoma
- +19 more
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +147 more
Jun 24, 2020
Metastatic Melanoma, Mucosal Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (biological, other,
Completed
- Metastatic Melanoma
- +4 more
- Bevacizumab
- +4 more
-
San Francisco, California
- +12 more
Jan 7, 2020
Acral Lentiginous Melanoma, Mucosal Melanoma Trial in Washington, Tampa, Hackensack (Nivolumab, Ipilimumab)
Unknown status
- Acral Lentiginous Melanoma
- Mucosal Melanoma
-
Washington, District of Columbia
- +3 more
Jan 7, 2020
Molecular Characterization of Primary Mucosal Melanoma
Unknown status
- Mucosal Melanoma
- Somatic Genetic
-
Reims, FranceChu Reims
Dec 13, 2019
Mucosal Melanoma Trial in Guangzhou (RT)
Unknown status
- Mucosal Melanoma
- RT
-
Guangzhou, Guangdong, ChinaLiXia Lu
Jan 27, 2018